Medifast, Inc. — 2015 Form 10-K Summary
Reporting period: Fiscal year ended December 31, 2015; filed March 15, 2016. Although the request identifies 2015 Q4, this is an annual report. It also reports unaudited quarterly results. Medifast sells weight-management and healthy-living products through its Health Coach, direct-to-consumer, franchise-center, and wholesale channels.
Key financial results
| Metric | FY 2015 | FY 2014 |
|---|---|---|
| Revenue | $272.8 million | $285.3 million |
| Gross profit / margin | $201.3 million / 73.8% | $209.2 million / 73.3% |
| Operating income / margin | $28.7 million / 10.5% | $30.2 million / 10.6% |
| Continuing-operations income | $19.6 million; diluted EPS $1.62 | $21.0 million; diluted EPS $1.65 |
| Net income | $20.1 million; diluted EPS $1.66 | $13.2 million; diluted EPS $1.03 |
| Cash from continuing operating activities | $33.1 million | $27.3 million |
| Cash and cash equivalents at year-end | $42.0 million | $24.5 million |
| Working capital / stockholders’ equity | $64.5 million / $88.6 million | $55.0 million / $80.5 million |
- Total operating cash flow, including discontinued operations, was $29.4 million. Investing activities used $0.2 million; financing activities used $11.7 million, including $10.5 million for share repurchases.
- Investment securities were $25.1 million at year-end. The company reported no long-term debt; liabilities included $219,000 of current capital-lease maturities.
- Q4 revenue was $61.3 million versus $62.3 million in Q4 2014. Q4 continuing-operations income was $3.9 million versus $2.6 million; net income was $3.9 million versus a $3.4 million loss.
Material changes versus prior period
- Revenue declined 4% year over year, following a 12% decline in 2014. Take Shape For Life revenue fell 2% to $202.2 million; Medifast Direct fell 15% to $48.7 million; Wholesale fell 20% to $4.8 million. Franchise-center revenue rose 11% to $17.1 million.
- Take Shape For Life remained the largest channel at 74.1% of revenue. Active Health Coaches reached 11,900 in Q4, up from 11,700 a year earlier under the company’s revised quarterly measurement; revenue per coach was $4,039 versus $3,896.
- Gross margin improved by 0.5 percentage points, attributed to price increases and shipping efficiencies. Operating income fell 5%, and continuing-operations income fell 7%, reflecting lower sales.
- Net income increased 52% largely because discontinued operations improved from a $7.8 million loss in 2014 to $0.5 million of income in 2015. The company had exited its corporate-owned weight-control-center model in 2014, selling 41 centers and closing 34.
- Medifast declared its first dividend, $0.25 per share, in December 2015, and authorized another $0.25-per-share dividend in March 2016. It repurchased $10.5 million of stock in 2015.
Outlook, risks and unusual items
- Management gave no specific revenue or earnings guidance. It anticipated a 2016 tax rate of approximately 33%–34%. The filing notes seasonal weakness in Q4 and typically stronger demand in January and February.
- Key risks include retaining and growing the independent Health Coach network; customer-acquisition and advertising effectiveness; intense competition and changing consumer preferences; reliance on third-party manufacturers for about 58% of products and on a single Maryland facility for the remaining 42%; product, health-claim and advertising litigation; regulatory requirements; and cybersecurity and privacy risks.
- SG&A included $2.1 million of extraordinary legal expense related to Schedule 13D filings in 2015. The comparable 2014 period included $2.6 million of such legal costs and a $2.0 million accrual for a franchise-loan guarantee. Management’s non-GAAP adjusted diluted EPS from continuing operations was $1.73 for 2015 versus $1.89 for 2014.
- A court entered a $2.1 million default judgment against Team Wellness companies in June 2015, including reimbursement for loan payments; claims against the personal guarantor remained pending. A separate TransformU dispute seeking more than $650,000 was settled in February 2016; the settlement amount is not stated. The company said other routine proceedings were not expected to materially affect results, financial position, or liquidity.
- Medifast had a 2012 FTC consent decree governing specified advertising procedures and disclosures. Management and the independent auditor reported effective internal control over financial reporting; the auditor issued an unqualified opinion on the financial statements.
Important facts for investors to verify
- Whether Health Coach growth and improved Q4 coach productivity can persist, and whether declines in direct and wholesale sales stabilize.
- Whether price and shipping efficiencies can sustain margins despite declining revenue and marketing investment.
- The cash-flow and balance-sheet implications of continued dividends, share repurchases, lease obligations, and any guarantees or pending legal matters.
- Progress on the Team Wellness guarantor litigation and the financial terms or effects of the TransformU settlement.
- Whether the stated 2016 tax-rate expectation and management’s operating assumptions are borne out; no explicit sales or earnings forecast is provided in this filing.